Chen, Ming-Huang <br/><br/>
Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.  [electronic resource] 

 -  Cancer  Jan 2013 
 - 293-303 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.27743  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Benzoquinones--administration & dosage<br/>Bile Duct Neoplasms--genetics<br/>Bile Ducts, Intrahepatic--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cholangiocarcinoma--genetics<br/>Drug Evaluation, Preclinical<br/>Female<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Genomics<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Inhibitory Concentration 50<br/>Isoxazoles--administration & dosage<br/>Lactams, Macrocyclic--administration & dosage<br/>Liver Neoplasms, Experimental--chemically induced<br/>MAP Kinase Signaling System<br/>Male<br/>Middle Aged<br/>Oligonucleotide Array Sequence Analysis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Resorcinols--administration & dosage<br/>Transcriptome<br/>Tumor Burden--drug effects